Companies · AI / ML
LOS ANGELES · CA, USA · AI / ML · refined from filed group “Other Technology” · founded 2014 · http://akidolabs.com
Diligence memoA one-page analyst read on Akido Labs, Inc. — recommendation, valuation, rhythm, risks.→Akido Labs, Inc. looks over-valued against its niche peers and is quiet on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the ai/ml sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Akido Labs, Inc. is one of 2067 AI / ML companies tracked from LOS ANGELES, CA, USA, on record since 2014. By capital raised it ranks among the largest (ahead of 97% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Rebuilding healthcare with AI at the core
For the first time in history, technology exists to create a healthcare system that anticipates your needs, responds with precision and is accessible to everyone -- regardless of financial means or geography. Since 2015, Akido Labs singular focus has been to make this vision a reality.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 20%.
Round size and date are reported; the stage label is inferred from round size (latest is Series C — a $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the ai/ml sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 2067 companies in AI / ML. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 97% of sector peers (real $). Modeled value above 97% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #1 of 16.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Akido Labs, Inc. this company | Series C | $84.3M | $676.4M | 1.68× |
| Rad AI, Inc. | Series C | $123.9M | $623.8M | 1.55× |
| Arize AI, Inc. | Series C | $111.2M | $585.5M | 1.45× |
| CAST AI Group, Inc. | Series C | $153.5M | $569.7M | 1.42× |
| Horizon 3 AI, Inc. | Series C | $148.5M | $554.6M | 1.38× |
| Positron AI, Inc. | Series C | $75.1M | $549.7M | 1.37× |
| Overland Ai Inc. | Series C | $122.3M | $502.5M | 1.25× |
| Moonvalley AI Inc. | Series C | $116.3M | $427.8M | 1.06× |
| Pactum AI, Inc. | Series C | $61.0M | $377.0M | 0.94× |
| General Counsel AI, Inc. | Series C | $67.2M | $355.2M | 0.88× |
| Abacum Inc. | Series C | $50.0M | $322.5M | 0.80× |
| Unify AI Business Corp | Series C | $58.2M | $305.9M | 0.76× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series C | $84.3M | 2025-03-11 | $561.7M | $676.4M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Andrew Adams | — | 12 other | 2025-03 |
| Rohit Gupta | — | 5 other | 2025-03 |
| John Greco | — | 1 other | 2025-03 |
| Jared Goodner | — | — | 2025-03 |
| Prasad Jeereddi | — | — | 2025-03 |
| Prashant Samant | — | — | 2025-03 |
Akido Labs, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Netomi, Inc. | AI / ML | Series C | $86.2M | $275.6M | same sector · same stage |
| Read AI, Inc. | AI / ML | Series C | $81.0M | $480.4M | same sector · same stage |
| Protect AI, Inc. | AI / ML | Series C | $80.8M | $801.8M | same sector · same stage |
| Auditoria.AI, Inc. | AI / ML | Series B | $60.8M | $250.4M | network1 shared operator · same sector |
| Positron AI, Inc. | AI / ML | Series C | $75.1M | $549.7M | same sector · same stage |
| Hayden AI Technologies Inc. | AI / ML | Series C | $95.6M | $968.2M | same sector · same stage |
| Percipient.ai Inc. | AI / ML | Series C | $99.9M | $199.7M | same sector · same stage |
| Hume AI Inc. | AI / ML | Series C | $69.9M | $646.6M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Parallel AI agents for healthcare admin | AI / ML | — | — | 81% |
| Glass Health, Inc. AI-Powered Clinical Decision Support & Ambient Scribing | AI / ML | Series A | $226.8M | 79% |
| Healthcare AI Automation, Inc. | AI / ML | Seed | $11.3M | 78% |
| Pair Team, Inc. Building the safety net of the future | AI / ML | Series B | $4.2M | 78% |
| Known Medicine Combining 3D cell culture & AI to translate drugs to clinical success | Healthtech | — | — | 77% |
| Human Ai Labs, Inc. | AI / ML | Series A | $44.5M | 77% |
| Caire Health Holdings, Inc. Semi-Autonomous Diagnostics for Emergent Care | Medical Devices | Series A | $57.9M | 77% |
| AIOS Building AI-native infrastructure for the next era of care. | AI / ML | — | — | 77% |
See where Akido Labs, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Akido Labs, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.